Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 14,683 | 15,445 | 14,180 | 15,287 | 14,345 |
| Cost of Goods | 5,449 | 6,024 | 5,726 | 6,199 | 6,034 |
| Gross Profit | 9,234 | 9,421 | 8,454 | 9,088 | 8,311 |
| Operating Expenses | 17,045 | 15,526 | 13,376 | 12,974 | 14,235 |
| Operating Income | -7,362 | -6,081 | -4,196 | -3,687 | -5,890 |
| Interest Expense | 19 | 16 | 19 | 24 | 12 |
| Pre-tax Income | -7,381 | -6,097 | -4,215 | -3,711 | -5,902 |
| Net Income Continuous | -7,381 | -6,097 | -4,215 | -3,711 | -5,902 |
| Net Income | $-7,381 | $-6,097 | $-4,215 | $-3,711 | $-5,902 |
| EPS Basic Total Ops | -0.12 | -0.10 | -0.07 | -0.06 | -0.10 |
| EPS Basic Continuous Ops | -0.12 | -0.10 | -0.07 | -0.06 | -0.10 |
| EPS Diluted Total Ops | -0.12 | -0.10 | -0.07 | -0.06 | -0.10 |
| EPS Diluted Continuous Ops | -0.12 | -0.10 | -0.07 | -0.06 | -0.10 |
| EBITDA(a) | $-7,081 | $-5,801 | $-3,916 | $-3,409 | $-5,614 |